What the pulmonary specialist should know about the new inhalation therapies - Laube, B.L.; Janssens, H.M.; de Jongh, F.H.C.; Devadason, S.G.; Dhand, R.; Diot, P.; Everard, M.L.; Horvath, I.; Navalesi, P.; Voshaar, T.; Chrystyn, H. (The European respiratory journal, 2011)
Keywords: Acquired Immunodeficiency Syndrome - drug therapy; Administration, Inhalation; Advisory Committees - standards; Aged; Aged, 80 and over; Asthma - drug therapy; Biological and medical sciences; Child; Child, Preschool; Cystic Fibrosis - drug therapy; Delivery. Postpartum. Lactation; Familial Primary Pulmonary Hypertension; Gynecology. Andrology. Obstetrics; Humans; Hypertension, Pulmonary - drug therapy; Lung Diseases - drug therapy; Medical sciences; Nebulizers and Vaporizers; Physician-Patient Relations; Pneumology; Pulmonary Disease, Chronic Obstructive - drug therapy; Pulmonary Medicine - standards; Respiration, Artificial - methods; Respiratory Therapy - standards; inhalation therapy; pulmonary delivery; Treatment; Lung; Delivery; Technique; inhalation treatment; Inhalation technique; Inhalation; Pneumology